Duration of maintenance anti-psychotic therapy after first -episode schizophrenia: a double-blind randomized placebo-control relapse prevention study

Trial Profile

Duration of maintenance anti-psychotic therapy after first -episode schizophrenia: a double-blind randomized placebo-control relapse prevention study

Completed
Phase of Trial: Phase IV

Latest Information Update: 17 Feb 2011

At a glance

  • Drugs Quetiapine (Primary)
  • Indications Psychotic disorders; Schizoaffective disorder; Schizophrenia
  • Focus Therapeutic Use
  • Most Recent Events

    • 17 Dec 2007 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 30 Mar 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top